This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

November 4–6, 2024Stockholm, Sweden

João Ribas
Principal at Novo Holdings


João Ribas is a Principal at Novo Holdings and an Executive Director at Orbis Medicines. He focusses on building and launching new therapeutic companies based on novel academic breakthroughs or asset spinouts. He brings operational and strategic experience together with deep scientific understanding. João serves on several boards including Asgard Therapeutics, Tribune Therapeutics, and Orbis Medicines. Prior to joining Novo Holdings, João worked at M Ventures, the corporate venture arm of Merck KGaA, participating in the investments in Plexium and Pantheon Biosciences. João holds a Ph.D. in Bioengineering from the University of Coimbra and performed his doctoral thesis at Harvard Medical School & Brigham and Women's Hospital. He helped start several companies and was the recipient of several entrepreneurial awards.

Agenda Sessions

  • Fireside chat in collaboration with YVC